Pfizer vaccine sold for up to $ 2,488 in Tehran – Eurasia Review
The Pfizer vaccine is sold in Tehran for 25 to 60 million tomans (about $ 1,036 to $ 2,488), a state daily said today. According to Hamshahri On a daily basis, vaccines are sold in districts of the capital equipped with modern refrigeration systems. Two doses of vaccine sell for between 25 and 60 million tomans. The difference in price depends on the injection site and the point of contact.
Hamshahri said the “unofficial vaccine market” flourished because immunization in Iran came to a halt due to a shortage of second doses, leaving many Iranians to search for vaccines on the black market.
Those in need are brought in by “trusted” sources and by presenting their national ID card, they can access the “unofficial” market to purchase Pfizer vaccines.
Iran’s Supreme Leader Ali Khamenei has banned the importation of American and British vaccines into a televised speech January 8.
In recent months, many countries, including the United States and the United Kingdom, have eased their lockdown restrictions after a large chunk of their population has been vaccinated. However, Iranian authorities are reporting the fifth peak of the COVID-19 outbreak, and the death toll and number of infections are still on the rise.
Iran has imported Russian and Chinese vaccines and has started vaccinating the elderly (over 75) and healthcare workers, however, vaccination has been stopped in the past two weeks.
The Iranian Ministry of Health announced yesterday that the use of the COV vaccine Iran Barakat has been authorized. It was then that according to the head of the Organization for Medical Affairs, responsible for authorizing vaccines, the third phase trials were not yet completed.
According to unofficial figures announced by the Paris-based opposition group NCRI, more than 312,200 people have died in the country from COVID-19. Iran’s health ministry put the death toll at 82,351, but many health officials have noted that the actual death toll is much higher.